最近在治疗儿童便秘方面取得的进展
1Division of Pediatric Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
针对儿科功能性便秘 (FC) 的新疗法正在出现,这是一个常见的疾病. 虽然林纳克洛提德现在已被FDA批准用于儿童,但对于个性化FC管理,进一步研究安全性和有效性至关重要.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 药理学 药理学是指药理学的学科.
- 手术干预 手术干预
背景情况:
- 功能性便秘 (FC) 影响了大量儿童,大约30%的儿童对标准治疗没有反应.
- 目前的管理往往涉及生活方式的改变和透性药,但新的治疗途径正在变得可用.
研究的目的:
- 审查当前和新兴的药理学,手术和神经调节疗法用于儿科功能性便秘.
- 讨论儿童这些不同治疗方式的疗效和安全数据.
主要方法:
- 对儿科FC的现有和新型治疗方案的文献综述.
- 来自临床研究和专家意见的疗效和安全数据的分析.
主要成果:
- 第一个药理学药物,林纳克洛提德,在2023年获得FDA批准,用于治疗6-17岁儿童的FC.
- 目前正在探索各种药理学,手术和神经调节方法,用于儿科FC管理.
结论:
- 对儿童群体新型FC治疗的安全性和疗效进行进一步的研究至关重要.
- 预计针对儿童FC管理的个性化方法,考虑到与成年人不同的病理生理学,可以改善结果.
更多相关视频
03:50Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
08:24Author Spotlight: Exploring the Potential of Massage Therapy in Cerebral Palsy Using Animal Models
Published on: August 11, 2023
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Irritable Bowel Syndrome III: Medical and Nursing Management
